Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2021

31.01.2021 | COVID-19 | Preclinical study Zur Zeit gratis

Covid-19 related oncologist’s concerns about breast cancer treatment delays and physician well-being (the CROWN study)

verfasst von: Katharine A. Yao, Deanna Attai, Richard Bleicher, Kristine Kuchta, Meena Moran, Judy Boughey, Lee G. Wilke, Jill R. Dietz, MD, Randy Stevens, Catherine Pesce, Katherine Kopkash, Scott Kurtzman, Terry Sarantou, David Victorson

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To examine how treatment delays brought on by the COVID-19 pandemic impacted the physical and emotional well-being of physicians treating these patients.

Methods

A cross-sectional survey of physician breast specialists was posted from April 23rd to June 11th, 2020 on membership list serves and social media platforms of the National Accreditation Program for Breast Centers and the American Society of Breast Surgeons. Physician well-being was measured using 6 COVID-19 burnout emotions and the 4-item PROMIS short form for anxiety and sleep disturbance. We examined associations between treatment delays and physician well-being, adjusting for demographic factors, COVID-19 testing and ten COVID-19 pandemic concerns.

Results

870 physicians completed the survey, 61% were surgeons. The mean age of physicians was 52 and 548 (63.9%) were female. 669 (79.4%) reported some delay in patient care as a result of the COVID-19 pandemic. 384 (44.1%) and 529 (60.8%) of physicians scored outside normal limits for anxiety and sleep disturbance, respectively. After adjusting for demographic factors and COVID-19 testing, mean anxiety and COVID-19 burnout scores were significantly higher among physicians whose patients experienced either delays in surgery, adjuvant chemotherapy, radiation, breast imaging or specialty consultation. A multivariable model adjusting for ten physician COVID-19 concerns and delays showed that “delays will impact my emotional well-being” was the strongest concern associated with anxiety, sleep disturbance and COVID-19 burnout factors.

Conclusions

Breast cancer treatment delays during the initial surge of the COVID-19 pandemic in the United States were associated with a negative impact on physician emotional wellness.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Holshue ML, DeBolt C, Lindquist S et al (2020) First Case of 2019 Novel Coronavirus in the United States. The New England journal of medicine 382(10):929–936CrossRef Holshue ML, DeBolt C, Lindquist S et al (2020) First Case of 2019 Novel Coronavirus in the United States. The New England journal of medicine 382(10):929–936CrossRef
4.
Zurück zum Zitat Dietz JR, Moran MS, Isakoff SJ et al (2020) Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. The COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat 181(3):487–497CrossRef Dietz JR, Moran MS, Isakoff SJ et al (2020) Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. The COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat 181(3):487–497CrossRef
7.
Zurück zum Zitat Gasparri ML, Gentilini OD, Lueftner D, Kuehn T, Kaidar-Person O, Poortmans P (2020) Changes in breast cancer management during the Corona Virus Disease 19 pandemic: an international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST). Breast 52:110–115CrossRef Gasparri ML, Gentilini OD, Lueftner D, Kuehn T, Kaidar-Person O, Poortmans P (2020) Changes in breast cancer management during the Corona Virus Disease 19 pandemic: an international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST). Breast 52:110–115CrossRef
8.
Zurück zum Zitat Kuderer NM, Choueiri TK, Shah DP et al (2020) Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 395(10241):1907–1918CrossRef Kuderer NM, Choueiri TK, Shah DP et al (2020) Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 395(10241):1907–1918CrossRef
9.
Zurück zum Zitat Robilotti EV, Babady NE, Mead PA et al (2020) Determinants of COVID-19 disease severity in patients with cancer. Nat Med 26(8):1218–1223CrossRef Robilotti EV, Babady NE, Mead PA et al (2020) Determinants of COVID-19 disease severity in patients with cancer. Nat Med 26(8):1218–1223CrossRef
10.
Zurück zum Zitat Lai J, Ma S, Wang Y et al (2020) Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open 3(3):e203976CrossRef Lai J, Ma S, Wang Y et al (2020) Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open 3(3):e203976CrossRef
11.
Zurück zum Zitat Barello S, Palamenghi L, Graffigna G (2020) Burnout and somatic symptoms among frontline healthcare professionals at the peak of the Italian COVID-19 pandemic. Psychiatry Res 290:113129CrossRef Barello S, Palamenghi L, Graffigna G (2020) Burnout and somatic symptoms among frontline healthcare professionals at the peak of the Italian COVID-19 pandemic. Psychiatry Res 290:113129CrossRef
12.
Zurück zum Zitat Pappa S, Ntella V, Giannakas T, Giannakoulis VG, Papoutsi E, Katsaounou P (2020) Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis. Brain Behav Immun 88:901–907CrossRef Pappa S, Ntella V, Giannakas T, Giannakoulis VG, Papoutsi E, Katsaounou P (2020) Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis. Brain Behav Immun 88:901–907CrossRef
13.
Zurück zum Zitat Shanafelt TD, Balch CM, Bechamps G et al (2010) Burnout and medical errors among American surgeons. Ann Surg 251(6):995–1000CrossRef Shanafelt TD, Balch CM, Bechamps G et al (2010) Burnout and medical errors among American surgeons. Ann Surg 251(6):995–1000CrossRef
14.
Zurück zum Zitat Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D (2008) The Development of Scales for Emotional Distress from the Patient-Reported Outcomes Measurement Information System (PROMIS): Depression, Anxiety, and Anger Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D (2008) The Development of Scales for Emotional Distress from the Patient-Reported Outcomes Measurement Information System (PROMIS): Depression, Anxiety, and Anger
15.
Zurück zum Zitat Buysse DJ, Yu L, Moul DE et al (2010) Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments. Sleep 33(6):781–792CrossRef Buysse DJ, Yu L, Moul DE et al (2010) Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments. Sleep 33(6):781–792CrossRef
18.
Zurück zum Zitat Freedman RA, Sedrak MS, Bellon JR, et al. (2020) Weathering the storm: managing older adults with breast cancer amid COVID-19 and beyond. J Natl Cancer Instit Freedman RA, Sedrak MS, Bellon JR, et al. (2020) Weathering the storm: managing older adults with breast cancer amid COVID-19 and beyond. J Natl Cancer Instit
19.
Zurück zum Zitat Masuda N, Sagara Y, Kinoshita T et al (2012) Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial. Lancet Oncol 13(4):345–352CrossRef Masuda N, Sagara Y, Kinoshita T et al (2012) Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial. Lancet Oncol 13(4):345–352CrossRef
20.
Zurück zum Zitat Spring LM, Gupta A, Reynolds KL et al (2016) Neoadjuvant endocrine therapy for estrogen receptor-positive breast cancer: a systematic review and meta-analysis. JAMA Oncol 2(11):1477–1486CrossRef Spring LM, Gupta A, Reynolds KL et al (2016) Neoadjuvant endocrine therapy for estrogen receptor-positive breast cancer: a systematic review and meta-analysis. JAMA Oncol 2(11):1477–1486CrossRef
21.
Zurück zum Zitat Desai A, Sachdeva S, Parekh T, Desai R (2020) COVID-19 and cancer: lessons from a pooled meta-analysis. JCO Glob Oncol 6:557–559CrossRef Desai A, Sachdeva S, Parekh T, Desai R (2020) COVID-19 and cancer: lessons from a pooled meta-analysis. JCO Glob Oncol 6:557–559CrossRef
22.
Zurück zum Zitat Dai M, Liu D, Liu M et al (2020) Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov 10(6):783–791PubMedPubMedCentral Dai M, Liu D, Liu M et al (2020) Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov 10(6):783–791PubMedPubMedCentral
23.
Zurück zum Zitat Bleicher RJ, Ruth K, Sigurdson ER et al (2012) Preoperative delays in the US Medicare population with breast cancer. J Clin Oncol: Off J Am Soc Clin Oncol 30(36):4485–4492CrossRef Bleicher RJ, Ruth K, Sigurdson ER et al (2012) Preoperative delays in the US Medicare population with breast cancer. J Clin Oncol: Off J Am Soc Clin Oncol 30(36):4485–4492CrossRef
24.
Zurück zum Zitat Bleicher RJ, Chang C, Wang CE et al (2019) Treatment delays from transfers of care and their impact on breast cancer quality measures. Breast Cancer Res Treat 173(3):603–617CrossRef Bleicher RJ, Chang C, Wang CE et al (2019) Treatment delays from transfers of care and their impact on breast cancer quality measures. Breast Cancer Res Treat 173(3):603–617CrossRef
25.
Zurück zum Zitat Kupstas AR, Hoskin TL, Day CN, Habermann EB, Boughey JC (2019) Effect of Surgery Type on Time to Adjuvant Chemotherapy and Impact of delay on breast cancer survival: a national cancer database analysis. Ann Surg Oncol 26(10):3240–3249CrossRef Kupstas AR, Hoskin TL, Day CN, Habermann EB, Boughey JC (2019) Effect of Surgery Type on Time to Adjuvant Chemotherapy and Impact of delay on breast cancer survival: a national cancer database analysis. Ann Surg Oncol 26(10):3240–3249CrossRef
26.
Zurück zum Zitat Bleicher RJ, Ruth K, Sigurdson ER et al (2016) Time to surgery and breast cancer survival in the United States. JAMA Oncol 2(3):330–339CrossRef Bleicher RJ, Ruth K, Sigurdson ER et al (2016) Time to surgery and breast cancer survival in the United States. JAMA Oncol 2(3):330–339CrossRef
27.
Zurück zum Zitat Yung R, Ray RM, Roth J et al (2020) The association of delay in curative intent treatment with survival among breast cancer patients: findings from the Women’s Health Initiative. Breast Cancer Res Treat 180(3):747–757CrossRef Yung R, Ray RM, Roth J et al (2020) The association of delay in curative intent treatment with survival among breast cancer patients: findings from the Women’s Health Initiative. Breast Cancer Res Treat 180(3):747–757CrossRef
28.
Zurück zum Zitat Dahlke AR, Johnson JK, Greenberg CC et al (2018) Gender differences in utilization of duty-hour regulations, aspects of burnout, and psychological well-being among general surgery residents in the United States. Ann Surg 268(2):204–211CrossRef Dahlke AR, Johnson JK, Greenberg CC et al (2018) Gender differences in utilization of duty-hour regulations, aspects of burnout, and psychological well-being among general surgery residents in the United States. Ann Surg 268(2):204–211CrossRef
29.
Zurück zum Zitat Hu YY, Ellis RJ, Hewitt DB et al (2019) Discrimination, abuse, harassment, and burnout in surgical residency training. Engl J Med 381(18):1741–1752CrossRef Hu YY, Ellis RJ, Hewitt DB et al (2019) Discrimination, abuse, harassment, and burnout in surgical residency training. Engl J Med 381(18):1741–1752CrossRef
30.
Zurück zum Zitat Coleman JR, Abdelsattar JM, Glocker RJ, Force RACT (2020) COVID-19 Pandemic and the Lived Experience of Surgical Residents, Fellows, and Early-Career Surgeons in the American College of Surgeons. J Am College Surg. Coleman JR, Abdelsattar JM, Glocker RJ, Force RACT (2020) COVID-19 Pandemic and the Lived Experience of Surgical Residents, Fellows, and Early-Career Surgeons in the American College of Surgeons. J Am College Surg.
31.
Zurück zum Zitat Del Carmen MG, Herman J, Rao S et al (2019) Trends and factors associated with physician burnout at a multispecialty academic faculty practice organization. JAMA Netw Open 2(3):e190554CrossRef Del Carmen MG, Herman J, Rao S et al (2019) Trends and factors associated with physician burnout at a multispecialty academic faculty practice organization. JAMA Netw Open 2(3):e190554CrossRef
32.
Zurück zum Zitat Dyrbye LN, Varkey P, Boone SL, Satele DV, Sloan JA, Shanafelt TD (2013) Physician satisfaction and burnout at different career stages. Mayo Clin Proc 88(12):1358–1367CrossRef Dyrbye LN, Varkey P, Boone SL, Satele DV, Sloan JA, Shanafelt TD (2013) Physician satisfaction and burnout at different career stages. Mayo Clin Proc 88(12):1358–1367CrossRef
Metadaten
Titel
Covid-19 related oncologist’s concerns about breast cancer treatment delays and physician well-being (the CROWN study)
verfasst von
Katharine A. Yao
Deanna Attai
Richard Bleicher
Kristine Kuchta
Meena Moran
Judy Boughey
Lee G. Wilke
Jill R. Dietz, MD
Randy Stevens
Catherine Pesce
Katherine Kopkash
Scott Kurtzman
Terry Sarantou
David Victorson
Publikationsdatum
31.01.2021
Verlag
Springer US
Schlagwort
COVID-19
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2021
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-021-06101-1

Weitere Artikel der Ausgabe 3/2021

Breast Cancer Research and Treatment 3/2021 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.